These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 9714698)
21. [Mechanism of sarcoid granuloma formation--participation of cytokines and chemokines]. Sugiyama Y; Oshikawa K Nihon Rinsho; 2002 Sep; 60(9):1728-33. PubMed ID: 12233067 [TBL] [Abstract][Full Text] [Related]
22. Cellular activation in the immune response of sarcoidosis. Zissel G Semin Respir Crit Care Med; 2014 Jun; 35(3):307-15. PubMed ID: 25007083 [TBL] [Abstract][Full Text] [Related]
23. Looking into the future of sarcoidosis: what is next for treatment? Miedema JR; Bonella F; Grunewald J; Spagnolo P Curr Opin Pulm Med; 2020 Sep; 26(5):598-607. PubMed ID: 32657837 [TBL] [Abstract][Full Text] [Related]
24. Cytokines, chemokines and other biomolecular markers in sarcoidosis. Gurrieri C; Bortoli M; Brunetta E; Piazza F; Agostini C Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S9-14. PubMed ID: 16457012 [TBL] [Abstract][Full Text] [Related]
25. NIH conference. Pulmonary sarcoidosis: a disease characterized and perpetuated by activated lung T-lymphocytes. Ann Intern Med; 1981 Jan; 94(1):73-94. PubMed ID: 7004303 [TBL] [Abstract][Full Text] [Related]
30. Thalidomide induces granuloma differentiation in sarcoid skin lesions associated with disease improvement. Oliver SJ; Kikuchi T; Krueger JG; Kaplan G Clin Immunol; 2002 Mar; 102(3):225-36. PubMed ID: 11890709 [TBL] [Abstract][Full Text] [Related]
31. [A new feasibility of immune stimulation in diseases with reduced cell immunity? (author's transl)]. Pavelka K; Müller W Cas Lek Cesk; 1981 May; 120(19):566-70. PubMed ID: 7237501 [No Abstract] [Full Text] [Related]
32. Sarcoidosis with Takayasu arteritis: a model of overlapping granulomatosis. A report of seven cases and literature review. Chapelon-Abric C; Saadoun D; Marie I; Comarmond C; Desbois AC; Domont F; Savey L; Cacoub P Int J Rheum Dis; 2018 Mar; 21(3):740-745. PubMed ID: 28791773 [TBL] [Abstract][Full Text] [Related]
33. Immunogenetics of Disease-Causing Inflammation in Sarcoidosis. Grunewald J; Spagnolo P; Wahlström J; Eklund A Clin Rev Allergy Immunol; 2015 Aug; 49(1):19-35. PubMed ID: 25791751 [TBL] [Abstract][Full Text] [Related]
34. Immunologic concepts relating to the pathogenesis of diffuse interstitial lung diseases (emphasizing granulomatous forms and idiopathic pulmonary fibrosis). Reynolds HY Trans Am Clin Climatol Assoc; 1980; 91():16-31. PubMed ID: 552178 [No Abstract] [Full Text] [Related]
35. Immunopathogenesis of sarcoidosis. Noor A; Knox KS Clin Dermatol; 2007; 25(3):250-8. PubMed ID: 17560302 [TBL] [Abstract][Full Text] [Related]
36. Epithelioid cell granulomatosis of the lung: new insights and concepts. Popper HH Sarcoidosis Vasc Diffuse Lung Dis; 1999 Mar; 16(1):32-46. PubMed ID: 10207940 [TBL] [Abstract][Full Text] [Related]
37. Involvement of the IP-10 chemokine in sarcoid granulomatous reactions. Agostini C; Cassatella M; Zambello R; Trentin L; Gasperini S; Perin A; Piazza F; Siviero M; Facco M; Dziejman M; Chilosi M; Qin S; Luster AD; Semenzato G J Immunol; 1998 Dec; 161(11):6413-20. PubMed ID: 9834133 [TBL] [Abstract][Full Text] [Related]
38. Sarcoidosis. Johns CJ; Scott PP; Schonfeld SA Annu Rev Med; 1989; 40():353-71. PubMed ID: 2524994 [TBL] [Abstract][Full Text] [Related]
39. Systemic sarcoidosis presenting as a granulomatous tattoo reaction secondary to interferon-alpha treatment for chronic hepatitis C and review of the literature. Nawras A; Alsolaiman MM; Mehboob S; Bartholomew C; Maliakkal B Dig Dis Sci; 2002 Jul; 47(7):1627-31. PubMed ID: 12141827 [TBL] [Abstract][Full Text] [Related]